
Sign up to save your podcasts
Or


The world's top neurotechnology companies can keep indefinite possession of the data generated by the brains of their trial subjects and customers, and even share it with third parties, according to upcoming research. FRANCE 24's Tech Editor Peter O'Brien tells us more.
By FRANCE 24 English5
44 ratings
The world's top neurotechnology companies can keep indefinite possession of the data generated by the brains of their trial subjects and customers, and even share it with third parties, according to upcoming research. FRANCE 24's Tech Editor Peter O'Brien tells us more.

7,722 Listeners

4 Listeners

0 Listeners

0 Listeners

2 Listeners

195 Listeners

1 Listeners

21 Listeners

0 Listeners

4 Listeners

913 Listeners

23 Listeners

6 Listeners

5 Listeners

39 Listeners

3 Listeners

4 Listeners

5 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

409 Listeners

1,869 Listeners